| Dr Martin H Redish, MD | |
|
2205 Mccallie Ave, Suite 102, Chattanooga, TN 37404-3230 | |
| (423) 493-5220 | |
| (423) 493-5228 |
| Full Name | Dr Martin H Redish |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 44 Years |
| Location | 2205 Mccallie Ave, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922096387 | NPI | - | NPPES |
| 3022104 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 016063 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkridge Medical Center | Chattanooga, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chattanooga Diagnostic Associates Llc | 9739272519 | 31 |
News Archive
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
Many parents worry about the potential influence the media may have on their children's self-esteem and body image. Stories about young women having excessive plastic surgery are enough to keep any parent up at night.
UMB Healthcare Services, a division of UMB Financial Corporation (NASDAQ: UMBF), announced today that they were selected by Blue Cross and Blue Shield of Kansas City to provide Health Savings Accounts (HSA) to its customers.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that preliminary results from its ENABLE Phase 2 proof-of-concept trial demonstrated that bafetinib, the Company's Bcr-Abl, Lyn and Fyn kinase inhibitor, was clinically active in a group of patients with relapsed or refractory B-cell chronic lymphocytic leukemia (B-CLL) who have failed several other treatments for their cancer.
Clemson University and Greenville Health System will establish a healthcare research powerhouse that will fuel growth in medical research and break-throughs, create opportunities for faculty, physicians and students and accelerate the flow of research funding into the Upstate, boosting the region's economy.
› Verified 8 days ago
| Entity Name | Chattanooga Diagnostic Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679772099 PECOS PAC ID: 9739272519 Enrollment ID: O20070910000993 |
News Archive
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
Many parents worry about the potential influence the media may have on their children's self-esteem and body image. Stories about young women having excessive plastic surgery are enough to keep any parent up at night.
UMB Healthcare Services, a division of UMB Financial Corporation (NASDAQ: UMBF), announced today that they were selected by Blue Cross and Blue Shield of Kansas City to provide Health Savings Accounts (HSA) to its customers.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that preliminary results from its ENABLE Phase 2 proof-of-concept trial demonstrated that bafetinib, the Company's Bcr-Abl, Lyn and Fyn kinase inhibitor, was clinically active in a group of patients with relapsed or refractory B-cell chronic lymphocytic leukemia (B-CLL) who have failed several other treatments for their cancer.
Clemson University and Greenville Health System will establish a healthcare research powerhouse that will fuel growth in medical research and break-throughs, create opportunities for faculty, physicians and students and accelerate the flow of research funding into the Upstate, boosting the region's economy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Martin H Redish, MD 2205 Mccallie Ave, Suite 102, Chattanooga, TN 37404-3230 Ph: (423) 493-5220 | Dr Martin H Redish, MD 2205 Mccallie Ave, Suite 102, Chattanooga, TN 37404-3230 Ph: (423) 493-5220 |
News Archive
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
Many parents worry about the potential influence the media may have on their children's self-esteem and body image. Stories about young women having excessive plastic surgery are enough to keep any parent up at night.
UMB Healthcare Services, a division of UMB Financial Corporation (NASDAQ: UMBF), announced today that they were selected by Blue Cross and Blue Shield of Kansas City to provide Health Savings Accounts (HSA) to its customers.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that preliminary results from its ENABLE Phase 2 proof-of-concept trial demonstrated that bafetinib, the Company's Bcr-Abl, Lyn and Fyn kinase inhibitor, was clinically active in a group of patients with relapsed or refractory B-cell chronic lymphocytic leukemia (B-CLL) who have failed several other treatments for their cancer.
Clemson University and Greenville Health System will establish a healthcare research powerhouse that will fuel growth in medical research and break-throughs, create opportunities for faculty, physicians and students and accelerate the flow of research funding into the Upstate, boosting the region's economy.
› Verified 8 days ago
Eric Peter Clarke, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2707 Citico Avenue, Chattanooga, TN 37406 Phone: 423-624-8588 Fax: 423-622-3069 | |
Julie Elizabeth Adams, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 979 E 3rd St Ste C225, Chattanooga, TN 37403 Phone: 423-778-5995 Fax: 423-778-5994 | |
Dr. J Paul Martz, D.O. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2415 Mccallie Ave, Chattanooga, TN 37404 Phone: 423-624-2696 Fax: 423-697-2055 | |
Fred Barry Hodges Iii, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 979 E 3rd St, Ste C-220, Chattanooga, TN 37403 Phone: 423-267-4585 Fax: 423-265-4098 | |
Dr. Jeremy Reginald Bruce, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-877-9297 | |
Dr. James Patterson Stone, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2415 Mccallie Ave, Chattanooga, TN 37404 Phone: 423-624-2696 Fax: 423-697-2055 | |
Dr. Adam M Caputo, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1736 Gunbarrel Rd, Chattanooga, TN 37421 Phone: 423-756-6623 |